Authors

• Jeffrey Crawford
• Thomas E. Stinchcombe (ORCID: https://orcid.org/0000-0002-3595-8011)
• Lin Gu (ORCID: https://orcid.org/0000-0002-7504-031X)
• Kent J. Weinhold (ORCID: https://orcid.org/0000-0003-4876-6737)
• Eziafa Oduah (ORCID: https://orcid.org/0000-0001-8517-6360)
• Liliana Lyniv
• C. G. Wood
• Scott Antonia (ORCID: https://orcid.org/0000-0002-6686-3824)
• Konstantin H. Dragnev (ORCID: https://orcid.org/0000-0001-8277-6993)
• Jacob M. Kaufman
• Dennis A. Wigle (ORCID: https://orcid.org/0000-0003-2407-1340)
• James M Isaacs
• Neal Ready
• Jeff Clarke
• Xiaofei Wang (ORCID: https://orcid.org/0009-0002-7143-0705)
• Betty Tong (ORCID: https://orcid.org/0000-0002-4135-971X)

Institutions

• Dartmouth–Hitchcock Medical Center (US)
• Cleveland Clinic (US)
• Mayo Clinic (US)
• Bon Secours Health System (US)
• Duke University (US)
• The Ohio State University Wexner Medical Center (US)
• Duke Medical Center (US)
• Duke University Health System (US)

Publication Details

Journal

Journal for ImmunoTherapy of Cancer

Published

2025-02-01

DOI

https://doi.org/10.1136/jitc-2024-010395

Citations

3

Primary Topic

Cancer Immunotherapy and Biomarkers

Type

article

Field-Weighted Citation Impact

3.14

Funders

• Merck Sharp and Dohme